• Thiamet G and Placental Ferroptosis Assay Logic

  2026-09-28

  Explore how Thiamet G, an O-GlcNAcase inhibitor, can help interrogate O-GlcNAc signaling in trophoblast ferroptosis. A new preeclampsia study connects HUWE1 modification to TfR1 turnover, iron uptake, and syncytialization—and offers practical guidance for designing causal assays.

• Cy5 TSA Fluorescence System Kit in Plaque Biology

  2026-09-27

  The Cy5 TSA Fluorescence System Kit offers a spatially focused way to investigate inflammatory signals in atherosclerotic tissue. This article connects tyramide chemistry to a recent NLRP3 study while clarifying what amplified staining can—and cannot—show about disease mechanisms.

• Mapping Metastatic Cell Identity with Cy5 TSA

  2026-09-26

  Metastatic head and neck cancer research increasingly depends on resolving where cellular identity changes occur—not only which genes change. This article connects recent HNSCC single-cell findings to spatial validation strategies, explaining how HRP-driven Cy5 tyramide deposition can help researchers investigate scarce targets while preserving tissue context.

• Tigecycline Workflows for Resistance Research

  2026-09-25

  Use Tigecycline as a controlled phenotypic probe alongside carbapenemase genotyping—not as a substitute for resistance-gene analysis. This workflow connects susceptibility testing with the plasmid-transfer findings in carbapenem-resistant Enterobacter cloacae while flagging the interpretation limits that matter at the bench.

• RBM28 Links Nucleolar Stress to p53 Suppression

  2026-09-25

  The study identifies RBM28 as a cancer-associated regulator that can move from the nucleolus into the nucleoplasm, bind p53, and suppress its transcriptional activity. It connects chemotherapy-associated stress and likely Chk1/2-dependent RBM28 phosphorylation at Ser122 to this change in localization, offering a mechanistic framework for studying nucleolar stress and p53 function.

• (S)-(+)-Ibuprofen: COX Inhibitor Evidence

  2026-09-24

  (S)-(+)-Ibuprofen is a stereochemically defined COX inhibitor for inflammation pathway research and related assay development. Product-reported enzyme and ecotoxicity values are useful starting points, but missing assay conditions limit direct comparisons.

• Actinomycin D: Practical Assay Design for Reliable Data

  2026-09-24

  A scenario-driven guide to using Actinomycin D in viability, proliferation, and mRNA stability experiments, with practical guidance on dosing, controls, and interpretation. It summarizes the documented handling profile of APExBIO SKU A4448 and links experimental decisions to relevant evidence.

• Tacrolimus (FK506) in Stress–Immune Signaling

  2026-09-23

  Tacrolimus (FK506) is an FKBP12-dependent calcineurin inhibitor used to investigate T-cell activation and cytokine signaling pathway modulation. It provides a tool for transplantation immunology research and immune response suppression, but it does not directly test the AMPK–SQSTM1–NRF2 feedback loop described in recent metabolic-stress research.

• Gefitinib (ZD1839) for EGFR Barrier Studies

  2026-09-23

  Use Gefitinib (ZD1839) to test whether EGFR signaling drives blue-light-induced skin barrier dysfunction, while retaining a validated workflow for cancer-cell signaling, proliferation, and resistance studies. This guide connects phosphoprotein measurements with functional barrier and viability readouts, plus practical controls for reproducible EGFR pathway inhibition.

• Pam3CSK4 TFA: Practical TLR1/2 Workflows

  2026-09-22

  Use Pam3CSK4 TFA as a defined TLR1/2 agonist to separate receptor-specific innate signaling from the complexity of whole-pathogen exposure. The workflow connects controlled cytokine stimulation with translational questions such as maternal IL-17A variation and neonatal Group B Streptococcus risk.

• From Hippo Biology to Spatial Assay Strategy

  2026-09-22

  A translational framework for using localized Cy5 tyramide amplification to interrogate Hippo-regulated hepatobiliary maturation, regenerative states, and low-abundance spatial biomarkers.

• KN-62: Applied CaMKII Workflows

  2026-09-21

  KN-62 enables pathway-focused experiments that connect calcium entry, CaMKII activity, secretion, metabolism, and cell-cycle control. This guide translates the compound’s biochemical profile into practical assay workflows while showing how the latest social-memory findings can inform neuronal assay design without overstating the evidence.

• Tigecycline as a Resistance-Transmission Assay Tool

  2026-09-21

  Tigecycline is more than a glycylcycline antibiotic comparator: it can help researchers interpret phenotype–genotype relationships in mobile carbapenemase systems. This article translates Guangdong CREC transmission data into a rigorous, orthogonal assay framework while defining the limits of that application.

• Cy5.5 NHS Ester for Hydrogel Tracking

  2026-09-20

  Cy5.5 NHS ester (non-sulfonated) converts amine-bearing proteins, nanoparticles, and hydrogel components into traceable near-infrared probes. This workflow shows how to use it for conjugation quality control, cartilage-delivery studies, and in vivo fluorescence imaging while avoiding common solubility, hydrolysis, and background problems.

• Plant Cell Lysis Buffer for WB and IP Guide

  2026-09-19

  Plant Cell Lysis Buffer for WB and IP (SKU K1126) supports non-denaturing protein preparation for Western blotting, immunoprecipitation, co-IP, and ELISA workflows. This scenario-based guide connects practical assay problems with formulation, storage, compatibility, and interpretation considerations for more consistent laboratory decisions.

553 records 3/37 page Previous Next 12345 下5页 Last page